Consonance Capital Management as of March 31, 2020
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 31 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Karyopharm Therapeutics (KPTI) | 10.3 | $138M | 7.2M | 19.21 | |
United Therapeutics Corporation (UTHR) | 9.5 | $128M | 1.4M | 94.83 | |
Aurinia Pharmaceuticals (AUPH) | 7.5 | $100M | 6.9M | 14.51 | |
Chemocentryx | 6.9 | $92M | 2.3M | 40.18 | |
Sarepta Therapeutics (SRPT) | 6.0 | $81M | 823k | 97.82 | |
Kadmon Hldgs | 4.9 | $65M | 16M | 4.19 | |
Omeros Corporation (OMER) | 4.5 | $60M | 4.5M | 13.37 | |
Caredx (CDNA) | 4.3 | $58M | 2.7M | 21.83 | |
Akebia Therapeutics (AKBA) | 4.0 | $54M | 7.1M | 7.58 | |
Epizyme | 3.8 | $51M | 3.3M | 15.51 | |
Uniqure Nv (QURE) | 3.6 | $49M | 1.0M | 47.45 | |
Assembly Biosciences | 3.5 | $47M | 3.2M | 14.83 | |
Principia Biopharma | 3.0 | $41M | 690k | 59.38 | |
Cytokinetics (CYTK) | 3.0 | $41M | 3.4M | 11.79 | |
Axogen (AXGN) | 2.8 | $37M | 3.6M | 10.40 | |
Kiniksa Pharmaceuticals | 2.6 | $35M | 2.2M | 15.48 | |
Aptose Biosciences | 2.6 | $34M | 5.8M | 5.94 | |
Retrophin | 2.5 | $34M | 2.3M | 14.59 | |
Coherus Biosciences (CHRS) | 2.4 | $33M | 2.0M | 16.22 | |
Krystal Biotech (KRYS) | 2.1 | $28M | 655k | 43.24 | |
Intra Cellular Therapies (ITCI) | 1.9 | $25M | 1.7M | 15.37 | |
Xenon Pharmaceuticals (XENE) | 1.7 | $22M | 2.0M | 11.34 | |
Liminal Biosciences | 1.6 | $22M | 3.3M | 6.69 | |
Bellus Health | 1.2 | $16M | 1.6M | 9.98 | |
Oxford Immunotec Global | 0.9 | $12M | 1.2M | 9.26 | |
Iveric Bio | 0.8 | $11M | 3.2M | 3.44 | |
Adma Biologics (ADMA) | 0.7 | $9.7M | 3.4M | 2.88 | |
Axovant Gene The | 0.7 | $8.9M | 3.7M | 2.44 | |
Ovid Therapeutics (OVID) | 0.6 | $7.7M | 2.6M | 2.98 | |
Biotelemetry | 0.1 | $1.9M | 49k | 38.50 | |
Apellis Pharmaceuticals (APLS) | 0.0 | $268k | 10k | 26.80 |